# 510(k) Summary

# Submitter information Contact person:

Neil Parker Senior Regulatory Affairs Specialist

# Address:

Siemens Healthcare Diagnostics 511 Benedict Avenue Tarrytown, NY 10591

# Phone:

914-524-2477   
914-524-2500 (fax)

Date summary prepared: February 28, 2011

Device Trade or Proprietary Names:

ADVIA Centaur Vitamin D Total Assay

ADVIA Centaur Vitamin D Total calibrators

ADVIA Centaur Vitamin D Total QC

ADVIA Centaur Vitamin D Total Master Curve Material

# Device Common/Usual Name or Classification Name:

Vitamin D Test System   
Calibrator   
Quality Control Material (Assayed and Unassayed)

Classification Number / Class:

21 CFR 862.1825 - Vitamin D Test System - Class II 21 CFR 862.1150 - Calibrator - Class II 21 CFR 862.1660 - Quality Control Material (Assayed and Unassayed) - Class I

# Product code:

# MRG - Vitamin D Test system JIT - Calibrator, Secondary JJX - single (specified) Analyte Controls (Assayed and Unassayed

This $5 1 0 ( k )$ summary of safety and effectiveness is being submitted in accordance with the requirements of 21 CFR 807.92.

The assigned 510(k) number is:

# Assay Predicate Device (including calibrators and controls):

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Predicate Device</td></tr><tr><td rowspan=1 colspan=1>Device Name</td><td rowspan=1 colspan=1>IDS 25-Hydroxy Vitamin D EIA</td></tr><tr><td rowspan=1 colspan=1>Common name</td><td rowspan=1 colspan=1>Vitamin D Test System</td></tr><tr><td rowspan=1 colspan=1>510(k) Number</td><td rowspan=1 colspan=1>K021163</td></tr><tr><td rowspan=1 colspan=1>Manufacturer</td><td rowspan=1 colspan=1>Immunodiagnostic Systems Ltd (IDS Ltd)</td></tr></table>

# Master Curve Material Predicate Device

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Predicate Device</td></tr><tr><td rowspan=1 colspan=1>Device Name</td><td rowspan=1 colspan=1>The VALIDATE Thyroid Calibration Verification TestSet</td></tr><tr><td rowspan=1 colspan=1>Common name</td><td rowspan=1 colspan=1>single (specified) Analyte Controls (Assayedand Unassayed)</td></tr><tr><td rowspan=1 colspan=1>510(k) Number</td><td rowspan=1 colspan=1>K062501</td></tr><tr><td rowspan=1 colspan=1>Manufacturer</td><td rowspan=1 colspan=1>Maine Standards Company</td></tr></table>

# Device Description:

The ADVIA Centaur Vitamin D Total assay is a one-pass 18 minute competitive immunoassay that uses an anti-fluorescein labeled (FITC) monoclonal antibody covalently bound to paramagnetic particles (PMP), one monoclonal antibody labeled with acridium ester (AE), and a Vitamin D analog labeled with fluorescein. An inverse relationship exists between the amount of Vitamin D present in the patient sample and the amount of relative light units (RLUs) detected by the system.

# Statements of Intended Use:

The ADVIA Centaur Vitamin D Total (VitD) assay is for the in vitro diagnostic use in the quantitative determination of total 25 (OH) vitamin D in human serum and plasma (EDTA, lithium heparin, sodium heparin) using the ADVIA Centaur XP system. The ADVIA Centaur VitD assay is intended as an aid in the determination of vitamin D sufficiency.

The ADVIA Centaur Vitamin D Total (VitD) Calibrators is for in vitro diagnostic use in calibrating ADVIA Centaur® systems Vitamin D Total (VitD) assay.

The ADVIA Centaur Vitamin D Total (VitD) QC is for in vitro diagnostic use to monitor the precision and accuracy of the ADVIA Centaur® VitD assay on the ADVIA Centaur systems.

The ADVIA Centaur® Vitamin D Total (VitD) Master Curve Material is for in vitro diagnostic use in the verification of calibration and reportable range of the ADVIA Centaur VitD assay.

# Comparisons to the Predicate Devices: Assay Similarities

<table><tr><td rowspan=1 colspan=1>Items</td><td rowspan=1 colspan=1>ADVIA Centaur Vitamin D Totalassay</td><td rowspan=1 colspan=1>IDS 25-OH Vitamin D EIAassay (Predicate Device)k021163</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Similarity</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Intended Use/Indication foruse</td><td rowspan=1 colspan=1>For the in vitro diagnostic use inthe quantitative determination oftotal 25 (OH) vitamin D in humanserum and plasma (EDTA,lithium-heparin, sodium-heparin)using the ADVIA Centaur XPsystem. The ADVIA Centaur VitDassay is intended as an aid in thedetermination of vitamin Dsufficiency.</td><td rowspan=1 colspan=1>SimilarThe IDS 25-OH Vitamin D EIAkit is an enzymeimmunoassayintended for the quantitativedetermination of 25-Hydroxyvitamin D and otherhydroxylated metabolites inhuman serum and plasma.Results are to be used inconjunction with other clinicaland laboratory data to assistthe clinician in the assessmentof vitamin D sufficiency inadult populations.</td></tr><tr><td rowspan=1 colspan=1>Sample Type</td><td rowspan=1 colspan=1>Serum and Plasma</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Reagent storage temperature</td><td rowspan=1 colspan=1>2-8°C</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Interpretation of results</td><td rowspan=1 colspan=1>Standard curve</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Expected Values</td><td rowspan=1 colspan=1>Deficiency &lt; 10 ng/mLInsufficiency 10-29 ng/mLSufficiency 30-100 ng/mLToxicity &gt; 100ng/mLRanges established forapparently healthy adults not onsupplements:10.6 ng/mL to 43.4 ng/mLn = 542</td><td rowspan=1 colspan=1>SameRanges established adults19.1 ng/mL to 57.6 ng/mLn = 36</td></tr></table>

# Assay Differences

<table><tr><td colspan="1" rowspan="1">Items</td><td colspan="1" rowspan="1">ADVIA Centaur Vitamin D Totalassay</td><td colspan="1" rowspan="1">IDS 25-OH Vitamin D EIAassay (Predicate Device)k021163</td></tr><tr><td colspan="3" rowspan="1">Differences</td></tr><tr><td colspan="1" rowspan="1">Platform</td><td colspan="1" rowspan="1">ADVIA Centaur XP</td><td colspan="1" rowspan="1">ELISA plate read on a platereader</td></tr><tr><td colspan="1" rowspan="1">Assay principle</td><td colspan="1" rowspan="1">Chemiluminescence</td><td colspan="1" rowspan="1">ELISA</td></tr><tr><td colspan="1" rowspan="1">Assay procedure</td><td colspan="1" rowspan="1">Automated</td><td colspan="1" rowspan="1">Manual</td></tr><tr><td colspan="1" rowspan="1">Approximate Assay time</td><td colspan="1" rowspan="1">18 minute</td><td colspan="1" rowspan="1">3.5 hours</td></tr><tr><td colspan="1" rowspan="1">Assay Range</td><td colspan="1" rowspan="1">4.2 to 150 ng/mL</td><td colspan="1" rowspan="1">5.9 to 120 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Traceability</td><td colspan="1" rowspan="1">Traceable to LC-MS/MS</td><td colspan="1" rowspan="1">Standardized using UVquantification of 25-(OH)vitamin D</td></tr><tr><td colspan="1" rowspan="1">Items</td><td colspan="1" rowspan="1">ADVIA Centaur Vitamin D Totalassay calibrators</td><td colspan="1" rowspan="1">IDS 25-OH Vitamin D EIAassay calibrators (PredicateDevice) k021163</td></tr><tr><td colspan="3" rowspan="1">Similarity</td></tr><tr><td colspan="1" rowspan="1">Intended Use/Indication foruse</td><td colspan="1" rowspan="1">For in vitro diagnostic use incalibrating ADVIA Centaur®systems Vitamin D Total (VitD)assay.</td><td colspan="1" rowspan="1">Similar</td></tr><tr><td colspan="1" rowspan="1">Antigen used in calibrators</td><td colspan="1" rowspan="1">25-(OH) vitamin D</td><td colspan="1" rowspan="1">same</td></tr><tr><td colspan="1" rowspan="1">Storage temperature</td><td colspan="1" rowspan="1">2-8°C</td><td colspan="1" rowspan="1">same.</td></tr></table>

# Calibrator Differences

<table><tr><td colspan="1" rowspan="1">Items</td><td colspan="1" rowspan="1">ADVIA Centaur Vitamin D Totalassay</td><td colspan="1" rowspan="1">IDS 25-OH Vitamin D EIAassay calibrators (PredicateDevice) k021163</td></tr><tr><td colspan="3" rowspan="1">Differences</td></tr><tr><td colspan="1" rowspan="1">Number of calibrators</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Matrix</td><td colspan="1" rowspan="1">Lyophilized human plasma</td><td colspan="1" rowspan="1">Lyophilized human serum</td></tr><tr><td colspan="1" rowspan="1">Items</td><td colspan="1" rowspan="1">ADVIA Centaur Vitamin D Totalassay controls</td><td colspan="1" rowspan="1">IDS 25-OH Vitamin D EIAassay controls (PredicateDevice) k021163</td></tr><tr><td colspan="3" rowspan="1">Similarity</td></tr><tr><td colspan="1" rowspan="1">Intended Use/Indication foruse</td><td colspan="1" rowspan="1">For in vitro diagnostic use tomonitor the precision andaccuracy of the ADVIA Centaur®VitD assay on the ADVIACentaur systems.</td><td colspan="1" rowspan="1">Similar</td></tr><tr><td colspan="1" rowspan="1">Antigen used in controls</td><td colspan="1" rowspan="1">25-(OH) vitamin D3</td><td colspan="1" rowspan="1">same</td></tr><tr><td colspan="1" rowspan="1">Number of Levels</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">same</td></tr><tr><td colspan="1" rowspan="1">Storage temperature</td><td colspan="1" rowspan="1">2-8°C</td><td colspan="1" rowspan="1">same</td></tr></table>

# QC Differences

<table><tr><td colspan="1" rowspan="1">Items</td><td colspan="1" rowspan="1">ADVIA Centaur Vitamin D Totalassay controls</td><td colspan="1" rowspan="1">IDS 25-OH Vitamin D EIAassay controls (PredicateDevice) k021163</td></tr><tr><td colspan="3" rowspan="1">Differences</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Matrix</td><td colspan="1" rowspan="1">Lyophilized human plasma</td><td colspan="1" rowspan="1">Lyophilized human serum</td></tr><tr><td colspan="1" rowspan="1">Items</td><td colspan="1" rowspan="1">ADVIA Centaur Vitamin D Totalassay MCMs</td><td colspan="1" rowspan="1">Maine Standards CompanyVALIDATE Thyroid CalibrationVerification Test Set(K062501)</td></tr><tr><td colspan="3" rowspan="1">Similarity</td></tr><tr><td colspan="1" rowspan="1">Intended Use/Indication foruse</td><td colspan="1" rowspan="1">The ADVIA Centaur® Vitamin DTotal (VitD) Master CurveMaterial is for in vitro diagnosticuse in the verification ofcalibration and reportable rangeof the ADVIA Centaur VitDassay.</td><td colspan="1" rowspan="1">The VALIDATE ThyroidCalibration Verification TestSet solutions are for in vitrodiagnostic use in theuantitative determination oflinearity, calibration verificationand verification of reportablerange in automated, semi-automated and manualchemistry systems.</td></tr><tr><td colspan="1" rowspan="1">Number of Levels</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">Same</td></tr></table>

# MCM Differences

<table><tr><td rowspan=1 colspan=1>Items</td><td rowspan=1 colspan=1>ADVIA Centaur Vitamin D Totalassay MCMs</td><td rowspan=1 colspan=1>Maine Standards CompanyVALIDATE ThyroidCalibrationVerification Test Set(K062501)</td></tr><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Human plasma</td><td rowspan=1 colspan=1>Human Serum</td></tr><tr><td rowspan=1 colspan=1>Form</td><td rowspan=1 colspan=1>Lyophilized</td><td rowspan=1 colspan=1>liquid</td></tr><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>25 (OH) vitamin D</td><td rowspan=1 colspan=1>Triiodothyronine (T3),Thyroxine (T4), humanThyroid Stimulating Hormone(TSH), and Cortisol.</td></tr></table>

# Performance:

Substantial equivalence for the ADVIA Centaur Vitamin D Total assay was demonstrated by testing several method performance characteristics including Analytical Sensitivity, Inearity, imprecision,method comparison, interfering substances, an specificity. The following ables summarize the analytical sensitivity, nerity, precision (total), interfering substances, specificity, serum / plasma equivalency and method comparison results.

All of the evaluation studies gave acceptable results compared to the predicate device. These studies support that the ADVIA Centaur Vitamin D Total assay (including the calibrators and controls) are substantially equivalent to the IDS 25-Hydroxy Vitamin D EIA that is currently marketed.

# Analytical Sensitivity

$\mathsf { L o B } = 1 . 6 0 \mathsf { n g / m L }$ LoD = 3.2 ng/mL $\mathsf { L o Q } = 4 . 2 \mathsf { n g / m L }$

# Imprecision

<table><tr><td rowspan=1 colspan=2>ADVIA Centaur Vitamin DTotal Assay</td><td rowspan=1 colspan=2>IDS 25-Hydroxy Vitamin D EIA</td></tr><tr><td rowspan=1 colspan=1>Level (ng/mL)</td><td rowspan=1 colspan=1>Total CV (%)n = 160</td><td rowspan=1 colspan=1>Level (ng/mL)</td><td rowspan=1 colspan=1>Inter assay CV (%)n = 11</td></tr><tr><td rowspan=1 colspan=1>11.7</td><td rowspan=1 colspan=1>11.1</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>18.0</td><td rowspan=1 colspan=1>9.6</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>32.4</td><td rowspan=1 colspan=1>9.8</td><td rowspan=1 colspan=1>40.3</td><td rowspan=1 colspan=1>4.6</td></tr><tr><td rowspan=1 colspan=1>49.9</td><td rowspan=1 colspan=1>8.2</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>55.8</td><td rowspan=1 colspan=1>7.8</td><td rowspan=1 colspan=1>72.0</td><td rowspan=1 colspan=1>6.4</td></tr><tr><td rowspan=1 colspan=1>132.1</td><td rowspan=1 colspan=1>4.8</td><td rowspan=1 colspan=1>132.0</td><td rowspan=1 colspan=1>8.7</td></tr></table>

# Specificity

The ADVIA Centaur VitD Total assay shows high specificity for 25(OH) vitamin D2 and 25(OH) vitamin $\mathsf { D } _ { 3 }$ The following compounds were tested with total 25(OH) vitamin D concentrations of 35 and $1 1 5 \eta \eta / \eta L$ Percent change is calculated as:

Percent cross-reactivity $=$ (corrected assay value / amount of compound spiked) $\pmb { \chi }$ 100

<table><tr><td>Compound</td><td>Concentration (ng/mL) Cross-Reactivity (%)</td></tr><tr><td>1, 25 (OH)2 Vitamin D2 100</td><td>4.0</td></tr><tr><td>1, 25 (OH)2 Vitamin D3 100</td><td>1.0</td></tr><tr><td>25 OH Vitamin D2 30</td><td>104.5</td></tr><tr><td>25 OH Vitamin D3 30</td><td>100.7</td></tr><tr><td>Paricalcitol</td><td>24 0.1</td></tr><tr><td>3-epi-25-OH Vitamin D3 100</td><td>1.1</td></tr><tr><td>Vitamin D2</td><td>1000 0.5</td></tr><tr><td>Vitamin D3 1000</td><td>0.3</td></tr></table>

# Interfering Substances

Interfering substances were tested as described in CLSI Document EP7-A2 using the ADVIA Centaur VitD assay.

<table><tr><td>Specimens That Are</td><td>Demonstrate ≤ 10% Change in Results Up To</td></tr><tr><td>hemolyzed</td><td>155 mg/dL of hemoglobin</td></tr><tr><td>lipemic</td><td>540 mg/dl of triglycerides</td></tr><tr><td>icteric</td><td>40 mg/dl. of conjugated bilirubin</td></tr><tr><td>icteric</td><td>40 mg/dl of unconjugated bilirubin</td></tr><tr><td>Specimens That Contain</td><td>Demonstrate ≤ 10% Change in Results Up To</td></tr><tr><td>cholesterol</td><td>350 mg/dL</td></tr><tr><td>uric acid</td><td>20 mg/dL</td></tr><tr><td>human immunoglobulin</td><td>12 g/dL</td></tr></table>

# Correlation

# (y =ADVIA Centaur Vitamin D assay vs. X $\updownarrow \equiv$ IDS 25-OH Vitamin D EIA assay comparison method/system)

<table><tr><td rowspan=1 colspan=6>IDS vs Centaur</td></tr><tr><td rowspan=1 colspan=1>X Axis</td><td rowspan=1 colspan=1>Y Axis</td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>r</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Y-int</td></tr><tr><td rowspan=1 colspan=1>IDS</td><td rowspan=1 colspan=1>Centaur VitD</td><td rowspan=1 colspan=1>195</td><td rowspan=1 colspan=1>.960</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>+2.22</td></tr></table>

# Serum / Plasma (lithium heparin and EDTA)

The ADVIA Centaur VITD assay was evaluated using different sample matrices and tube collection types. A matrix study was performed using matched specimens drawn in different tube types,including serum red top, SST, EDTA, lithium heparin, and sodium heparin. Vitamin D values ranged from 11.9 to $1 3 6 . 9 \mathrm { n g / m L }$ (29.8 to 342.3 nmol/L). Linear regression analysis was performed using the following:

serum $( { \pmb x } )$ vs. SST (y1) serum $( { \pmb x } )$ vs. EDTA (y2) serum $( { \pmb x } )$ vs. lithium heparin (y3) serum $( { \pmb x } )$ vs. sodium heparin (y4)

No significant differences between tube types was observed. The following results were obtained:

<table><tr><td>Tube Types</td><td></td><td>Range (ng/mL)</td><td>Slope</td><td>Intercept</td><td>R</td></tr><tr><td>Serum vs. SST</td><td>N 231</td><td>11.9 - 136.9</td><td>1.01</td><td>-0.33</td><td>0.994</td></tr><tr><td>Serum vs. EDTA</td><td>231</td><td>11.9 - 136.9</td><td>1.09</td><td>-0.17</td><td>0.993</td></tr><tr><td>Serum vs. Lithium Heparin</td><td>231</td><td>11.9 136.9</td><td>1.04</td><td>0.18</td><td>0.992</td></tr><tr><td>Serum vs. Sodium Heparin</td><td>231</td><td>11.9 * 136.9</td><td>1.04</td><td>0.90</td><td>0.992</td></tr></table>

# Conclusions:

The Siemens Healthcare Diagnostics ADVIA Centaur Vitamin D Total assay (including calibrators and controls) is substantially equivalent to other products in commercial distribution intended for similar use. Most notably, it is substantially equivalent to the currently marketed IDS 25-Hydroxy Vitamin D EIA (K021163).

The Siemens Healthcare Diagnostics ADVIA Centaur Vitamin D Total assay MCMs are substantially equivalent to other products in commercial distribution intended for similar use. Most notably, it is substantially equivalent to the currently marketed VALIDATE Thyroid Calibration Verification Test Set (K062501).

Siemens Healthcare Diagnostics, Inc. c/o Mr. Neil Parker   
511 Benedict Avenue   
Tarrytown, New York 10509

Re: k110586 Trade Name: ADVIA Centaur Vitamin D Total (VitD) Assay ADVIA Centaur Vitamin D Total (VitD) Calibrators ADVIA Centaur Vitamin D Total (VitD) QC ADVIA Centaur Vitamin D Total (VitD) Master Curve Material Regulation Number: 21 CFR $\ S 8 6 2 . 1 8 2 5$ EY Regulation Name: Vitamin D Test System Regulatory Class: Class II Product Codes: MRG, JIS, JJX Dated: September 15, 2011 Received: September 16, 2011

Dear Dr. Neil Parker,

We have reviewed your Section 510(k) premarket notification of intent to market the device refcrenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food; Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2-

If yu desie speciic advice or your device on ur labeling regulaton (21 R Pr 01), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entiled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Offce of Surveillance and Biometric's (OSB's) Division of Postmarket Surveilance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, Internatinal and Consumer Assistance at its toll-ree number (800) 638-204)or (30179- 5680 or at its Internet address htp://www.fda.gov/MedicalDevices/ResourcesforYou/ndustry/defauit.htm.

Sincerely yours,

![](images/8e48d5c048c83d4aa337502e80b7da4bc9caf8a7a4582c634a51cfc365800cf1.jpg)

Courtney H. Lias, Ph.D.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

Enclosure

# Indication for Use

510(k) Number (if known): K110586 Device Name: ADVIA Centaur Vitamin D Total Assay Indication for Use:

The ADVIA Centaur Vitamin D Total (VitD) assay is for in vitro diagnostic use in the quantitative determination of total 25 (OH) vitamin D in human serum and plasma (EDTA, lithium-heparin, sodium-heparin) using the ADVIA Centaur XP system. The ADVIA Centaur VitD assay is intended as an aid in the determination of vitamin D sufficiency.

The ADVIA Centaur Vitamin D Total (VitD) Calibrators is for in vitro diagnostic use in calibrating ADVIA Centaur $\mathfrak { Q }$ systems Vitamin D Total (VitD) assay.

The ADVIA Centaur Vitamin D Total (VitD) QC is for in vitro diagnostic use to monitor the precision and accuracy of the ADVIA Centaur $\textsuperscript { \textregistered }$ VitD assay on the ADVIA Centaur systems.

The ADVIA Centaur $\textsuperscript { \textregistered }$ Vitamin D Total (VitD) Master Curve Material is for in vitro diagnostic use in the verification of calibration and reportable range of the ADVIA Centaur VitD assay.